| Pitisuttithum, Punnee |
NCT06803524: 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination |
|
|
| Not yet recruiting | 4 | 90 | NA | Pertagen® vaccine, Adacel® vaccine | Mahidol University, BioNet-Asia Co., Ltd. | Pertussis | 03/26 | 03/26 | | |
NCT04548518: Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly |
|
|
| Recruiting | 3 | 816 | RoW | GPO Tri Fluvac vaccine, Licensed influenza vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 06/23 | 12/23 | | |
IVICHIK001, NCT04566484: Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia |
|
|
| Active, not recruiting | 2/3 | 3210 | RoW | BBV87 Chikungunya vaccine, Normal Saline | International Vaccine Institute | Chikungunya | 07/22 | 12/23 | | |
NCT01931358: Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E |
|
|
| Active, not recruiting | 2 | 360 | RoW | ALVAC-HIV, AIDSVAX B/E, ALVAC-HIV Placebo, AIDSVAX B/E Placebo | U.S. Army Medical Research and Development Command, National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 12/21 | 12/21 | | |
NCT05109559: Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine |
|
|
| Recruiting | 1/2 | 690 | RoW | Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp | Mahidol University, National Vaccine Institute, Thailand, International Vaccine Institute, Janssen Pharmaceuticals | SARS-CoV-2 Infection | 12/23 | 12/24 | | |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Recruiting | 1 | 120 | RoW | IHV01, A244, ALFQ, Placebo | U.S. Army Medical Research and Development Command, Duke University, University of Maryland, Baltimore, Case Western Reserve University | HIV | 05/24 | 05/27 | | |
NCT06279624: Effectiveness of the PCV13 in Older Thai Adults |
|
|
| Not yet recruiting | N/A | 840 | NA | | Mahidol University, National Research Council of Thailand | Community-acquired Pneumonia | 03/25 | 06/25 | | |
NCT06220747: Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women |
|
|
| Recruiting | N/A | 760 | RoW | | Mahidol University, National Research Council of Thailand | Hpv | 03/25 | 06/25 | | |
NCT06700876: Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT |
|
|
| Recruiting | N/A | 160 | RoW | | Mahidol University, National Research Council of Thailand | Tuberculosis (TB), End-Stage Kidney Disease | 12/26 | 06/27 | | |
| Bodhidatta, Ladaporn |
| Recruiting | N/A | 100 | RoW | Primaquine | Armed Forces Research Institute of Medical Sciences, Thailand, University of North Carolina, Chapel Hill | Malaria, Vivax Malaria, Relapse, CYP2D6 Polymorphism | 06/21 | 12/24 | | |
| Phonrat, Benjaluck |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Luvira, Viravarn |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Phumratanaprapin, Weerapong |
| Not yet recruiting | 2 | 1000 | RoW | Ribavirin, Molnupiravir, Favipiravir | University of Oxford | Respiratory Syncytial Virus, Respiratory Syncytial Virus, Human | 01/27 | 01/27 | | |
PLATCOV, NCT05041907: Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 |
|
|
| Recruiting | 2 | 3800 | RoW | Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™), Hydroxychloroquine, No treatment, Monoclonal antibodies, Fluoxetine, Molnupiravir, Sotrovimab, Ensitrelvir, Favipiravir, Ivermectin, Remdesivir, Atilotrelvir/ritonavir, Metformin, Nirmatrelvir/ritonavir, Nirmatrelvir | University of Oxford | COVID-19 | 01/27 | 01/27 | | |
| Recruiting | 2 | 3000 | RoW | Oseltamivir, Favipiravir, Zanamivir, Baloxavir, Molnupiravir, Peramivir, Laninamivir, Oseltamivir and Baloxavir, Oseltamivir and Favipiravir, Favipiravir and Baloxavir | University of Oxford | Influenza, Influenza, Human | 01/27 | 01/27 | | |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Muangnoicharoen, Sant |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Pitisuthitham, Arom |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
| Kamolratanakul, Supitcha |
NCT05895955: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais |
|
|
| Active, not recruiting | 1/2 | 290 | RoW | TetraFluvac TF vaccine, Vaxigrip vaccine | Mahidol University, The Government Pharmaceutical Organization | Influenza | 03/24 | 07/25 | | |
